PMAM
MRVI icon

Picton Mahoney Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Picton Mahoney Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-62,066
Closed -$1.76M – 778
2022
Q2 		$1.76M Buy
62,066
+56
+0.1% +$1.77K 0.07% 440
2022
Q1 		$2.19M Sell
62,010
-10,160
-14% -$341K 0.08% 351
2021
Q4 		$3.02M Buy
72,170
+15,720
+28% +$637K 0.07% 237
2021
Q3 		$2.77M Buy
+56,450
New +$2.75M 0.1% 251

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Picton Mahoney Asset Management's MRVI Position: Q3 2022 in Review

Picton Mahoney Asset Management sold out of Maravai LifeSciences (MRVI) in Q3 2022, closing a stake of 62,066 shares — an estimated $1.76M sold.

Picton Mahoney Asset Management first reported a position in MRVI in Q3 2021 and held it in 4 quarters. The position peaked at $3.02M in Q4 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

  • Picton Mahoney Asset Management reported no remaining Maravai LifeSciences position as of Q3 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 62,066 Maravai LifeSciences shares in Q3 2022, an estimated $1.76M.
  • Picton Mahoney Asset Management first reported a position in Maravai LifeSciences in Q3 2021 and held it in 4 quarters.
  • Picton Mahoney Asset Management's Maravai LifeSciences position peaked at $3.02M in Q4 2021.
  • 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2022, filed 9 Nov 2022.